Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.